CompletedPHASE1, PHASE2NCT05998395
JAK/STAT Inhibition in CNS Kohlmeier-Degos Disease
Studying Malignant atrophic papulosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Principal Investigator
- Cornelia D Cudrici, M.D., M.DNational Heart, Lung, and Blood Institute (NHLBI)
- Intervention
- Ruxolitinib(drug)
- Enrollment
- 1 enrolled
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2023 – 2025
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05998395 on ClinicalTrials.gov